|
⚲
|
| Keyboard |
| Goodman Jesse
✚
|
|
|---|---|
| CIK # | 0001756929 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001756929] | |
| 4 | [0001756929] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Goodman Jesse | |
| Intellia Therapeutics Inc | |
| BiomX Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-07-01 | Sell | 1,547 | $9.23 | 14,279 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-06-30 | Sell | 1,547 | $9.56 | 14,789 |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2025-06-11 | Grant | 11,450 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-06-11 | Grant | 8,000 | $0.00 | |
|
BiomX Inc PHGE
Common Stock Options - right to Buy · derivative
|
2025-04-14 | Grant | 17,600 | $0.00 | |
|
BiomX Inc PHGE
Common Stock Options - Right to Buy · derivative
|
2024-07-11 | Grant | 264,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2024-06-12 | Grant | 11,515 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-06-12 | Grant | 7,737 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2023-06-14 | Grant | 4,425 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2023-06-14 | Grant | 6,473 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2022-06-14 | Grant | 5,197 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2022-06-14 | Grant | 7,688 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2021-06-23 | Grant | 3,382 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2021-06-23 | Grant | 2,094 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2020-06-18 | Grant | 19,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock option (right to buy) · derivative
|
2019-05-21 | Grant | 19,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (Right to Buy) · derivative
|
2018-10-29 | Grant | 38,000 | $0.00 |